GlaxoSmithKline Business Development Manager Salaries in Dalton, GA
The average GlaxoSmithKline Business Development Manager in Dalton, GA earns an estimated $158,968 annually, which includes an estimated base salary of $127,501 with a $31,467 bonus. GlaxoSmithKline's Business Development Manager compensation is $26,827 more than the US average for a Business Development Manager. Business Development Manager salaries at GlaxoSmithKline in Dalton, GA can range from $55,000 - $306,000.
In Dalton, GA, The Business Development Department at GlaxoSmithKline earns $9,828 more on average than the Marketing Department.
Last updated 2 years ago.
- $127,501
- avg. base
- $31,467
- avg. bonus
Business Development Manager Salaries at GlaxoSmithKline
In Dalton, GA, Business Development Managers earn $2,432 more than Business Development Managers, and $52,434 less than Directors of Business Development.
Compensation at GlaxoSmithKline by Department
In Dalton, GA, The Business Development Department averages $9,828 more than the Marketing Department, and $1,796 less than the Engineering Department
Business Development Manager Compensation by Gender (All Companies)
The average female Business Development Manager at companies similar size to GlaxoSmithKline reported making $151,865, while the average male Business Development Manager at similar sized companies reported making $160,499.
Business Development Manager Compensation by Ethnicity (All Companies)
The average Hispanic or Latino Business Development Manager at companies similar size to GlaxoSmithKline reported making $180,546, while the average African American/Black Business Development Manager at similar sized companies reported making $121,400.
How Business Development Managers at GlaxoSmithKline Rate Their Compensation
The majority of Business Development Managers at GlaxoSmithKline believe they're compensated fairly. 100% of Business Development Managers at GlaxoSmithKline say they receive annual bonuses, and the majority (54%) are satisfied with their benefits. See more compensation ratings at GlaxoSmithKline
